BA regulates PPAR-γ levels, inhibits NF-κB activation and MLCK expression, suppresses MLC2 phosphorylation, reduces inflammation, and enhances tight junction expression, thereby treating IBD. Here, PPARG is linked to inflammatory bowel disease.